CHINARES PHARMA (03320.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec24

Huaxin Pharmaceutical Subsidiaries Obtain Clinical Trial Approval and Market Approval for New Drugs

06:15

Dec15

Huahuaipuoyi Commerce Completes RMB 3 Billion Medium-Term Note Issuance

12:40

Dec10

Huahuaikang Medicine's Two Drugs Included in National Health Insurance Directory

01:37

Dec2

Huahuaipharma Subsidiary's Pioglitazone Hydrochloride Dispersible Tablets Pass Consistency Evaluation

05:34

Nov20

China Resources Medicine Co., Ltd. Established with a Registered Capital of 30 Million RMB

07:41

Nov10

Shuren Sanjiu Secures Exclusive Rights to Helkos in China

09:48

Schedules & Filings

Schedules

Filings

Oct31

Distribution Plan(CST)

Cash dividend 0.0789 HKD

Sep12

Distribution Plan(CST)

Cash dividend 0.0789 HKD

Sep11

Distribution Plan(CST)

Cash dividend 0.0789 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More